[1]巩付华(综述)展淑琴(审校).强啡肽A及其与缺血性脑损伤关系的研究进展[J].三才期刊采编系统演示平台,2015,1期(04):251-252.[doi:10.3969/j.issn.1007-0478.2015.04.018]
点击复制

强啡肽A及其与缺血性脑损伤关系的研究进展
分享到:

《三才期刊采编系统演示平台》[ISSN:1008-0341/CN:37-1280/R]

卷:
第1期
期数:
2015年04期
页码:
251-252
栏目:
综述
出版日期:
2015-12-31

文章信息/Info

文章编号:
1007-0478(2015)04-0251-03
作者:
巩付华(综述)展淑琴(审校)
710004 西安交通大学第二附属医院神经内科[巩付华(研究生)展淑琴(通信作者)]
分类号:
R743
DOI:
10.3969/j.issn.1007-0478.2015.04.018
文献标志码:
A

参考文献/References:

1 Honda Z. Fc epsilon and Fc gamma receptor signaling in diseases.Springer Scmin Immunopathol, 2006,28(4):365-375.
2 Christophe A, Gerald WZ. Opioid, cheating on its receptors exacerbates pain. Nature Neuroscience,2006,9(12):1465-1467.
3 洪新如,卢晓欣,陈新民.强啡肽A(1-13)在新生鼠缺氧缺血性脑损伤中作用机制的实验研究.中国现代医学杂志,2003,13(1):9-11.
4 卢晓欣,洪新如,王成海,等.强啡肽A(1-13)在新生鼠缺氧、缺血性脑损伤中的作用.中华妇产科杂志,1997,32(4):198-201.
5 Hong X',Zheng L,Chen X.Changes of dynorphinA(1-13)on the treatment of hypoxic-ischemic brain injury by the brain-derived neurotropic factor in neonatal rats.Zhonghua Yi Xue Za Zhi,2002,82(23):1637-1640.
6 Baskin DS,Kuroda H,Hosobuchi Y,et al. Treatment of stroke with opiate antagonists--effects of exogenous antagonists and dynorphin1-13.Neuropeptides,1985,5(4-6):307-310.
7 张惠敏,张德英,郎恩千. 脑梗塞患者血浆β-内啡肽及强啡肽A1-13含量的变化.中风与神经疾病杂志,1997,14(3):145-146.
8 展淑琴,ZHOU An,郭新奎,等. 脑缺血大鼠脑皮层中强啡肽A(1-13)的经时表达及脑含水量的变化.西安交通大学学报(医学版),2009,30(2):145-148.
9 Kao TK, Ou YC, Liao SL, et al.Opioids modulate post-ischemic progression in a rat model of stroke.Nearochem Int,2008,52(6):1256-1265.
10 Chen CJ, Cheng FC, Liao SL, et a1.Effects of naloxonelacate, pyruvate metabolism and antioxidant enzyme activity in rat cerebral isehemia/reperfusion.J Neurosci Lett,2000,287(2):113-116.
11 盛宝英,陆晓红,王志群,等. 脑梗死患者血浆β-内啡肽、强啡肽A(l—13)含量及纳洛酮的保护作用研究.中国急救医学, 2004, 24(2): 142-143.
12 Itoh J, Ukai M, Kameyama T. U-50, 488 H, a kappa-opioid receptor agonist, markedly prevents memory dysfunctions introduced by transcient cerebral ischemia in mice. Brain Res,1993,619(1-2):223-228.
13 张晓彪,崔尧元,余 勇,等.强啡肽 A( 1-13)改善局灶性脑缺血后记忆障碍的研究.中国行为医学科学,1997,6(4):246-248.
14 Mamiya T, Hasegawa Y, Hiramatsu M. Dynorphin a(1-13)alleviated stress-induced behavioral impairments in mice. BiolPharm Bull, 2014, 37(8): 1269-1273.
15 Knoll AT1, Carlezon WA Jr. Dynorphin, stress, and depression. Brain Res,2010,16(1314): 56-73.
16 Ruisanchez E, Cselenyak A, Papp RS,et al.Perivascular expression and potent vasoconstrictor effect of dynorphin A in cerebral arteries. PLoS One, 2012,7(5): e37798.
17 Zhan S, Zhao H, J white A, et al. Defective neuropeptide processing and ischemic brain injury:a study on proprotein convertase 2 and its substrate neuropeptide in ischemic brains. J Cereb Blood Flow Metab,2009,29(4):698-706.
18 展淑琴,An Zhou,Tao Yang,等. 脑缺血大鼠脑组织中强啡肽A(1-8)的含量及含水量的变化.陕西医学杂志,2012,41(6):643-645.
19 Kong LY, Jeohn G, Hudson PM, et al. Reduction of lipopolysaccharide-induced neurotoxicty in mouse mixed cortical neuron/glia cultures by ultralow concentrations of dynorphins. J Biomed Sci,2000,7(3):241-247.
20 Rashid M, Wangler NJ, Yang L,et al.Functional up-regulation of endopeptidase neurolysin during post-acute and early recovery phases of experimental stroke in mouse brain. Neurochem, 2014, 129(1):179-189.
21 Benyo Z,Wahl M. Opiate receptor-mediated mechanisms in the regulation of cerebral blood flow. Cerebrovasc Brain Metab Rev,1996,8(4):326-357.
22 Malan TP, Ossipov MH, Gardell LR, et al. Extraterritorial neuropathic pain correlates with multisegmental elevation of spinal dynorphin in nerve-injured rats. Pain,2000,86(1-2):185-194.
23 洪欣茹,刘丽珍,卢晓欣,等. 强啡肽A在新生鼠缺氧、缺血性脑损伤中的阿片样和非阿片样受体机制. 中国康复医学杂志,2003,18(6): 345-347.
24 Tang Q, Lynch RM, Porreca F, et al. Dynorphin A elicits an increase in intracellular calcium in cultured neurons via a non-opioid, non-NMDA mechanism.J Neurophsiol,2000,83(5):2610-2615.

备注/Memo

备注/Memo:
2014-11-12收稿 2014-12-10修稿
基金项目:国家自然科学基金项目(No. 81070999);
中央高校基本科研业务费专项资金资助(西安交通大学,No.xjj2014153, No.2009-95);
西安交通大学第二附属医院人才培养专项科研基金科技骨干项目(No.RC(GG)201109)
更新日期/Last Update: 2015-08-30